Bastian Czogalla

Vitamin D and VDR in Gynecological Cancers-A Systematic Review.

Cyclic transcutaneous bleeding after repeated cesarean section deliveries.

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients.

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients.

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis.

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.

Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation.

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs).

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.

The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.

A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape.

PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.